Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Journal of Cancer|August 17, 2019
The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic CancerJin-Zhi Xu, Wen-Quan Wang, Wu-Hu Zhang, et al.
Acta Pharmacologica Sinica|April 3, 2023
A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancerTing Wang, Yi Qin, Zeng Ye, et al.
Journal of Cancer|October 2, 2018
The Significance of Liquid Biopsy in Pancreatic CancerZi-Hao Qi, Hua-Xiang Xu, Shi-Rong Zhang, et al.
Plos One|August 14, 2013
Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancerWen-Quan Wang, Liang Liu, Hua-Xiang Xu, et al.
Pancreas|April 26, 2023
Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors: Clinicopathological Analysis of 223 Cases and Whole Exome Sequencing of a Multifocal CaseHai-Feng Hu, Yu-Heng Hu, Xiao-Wu Xu, et al.
International Journal of Oncology|February 14, 2018
RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signalingZi-Hao Qi, Hua-Xiang Xu, Shi-Rong Zhang, et al.
International Journal of Oncology|November 28, 2025
[Corrigendum] RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signalingZi-Hao Qi, Hua-Xiang Xu, Shi-Rong Zhang, et al.
Acta Pharmacologica Sinica|December 6, 2023
SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancerHai-di Chen, Zeng Ye, Hai-Feng Hu, et al.
International Journal of Cancer|November 25, 2020
Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinomaTian-Jiao Li, Hao Li, Wu-Hu Zhang, et al.
Oncotarget|July 11, 2014
The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenibWen-Quan Wang, Liang Liu, Hua-Xiang Xu, et al.
Pageof 11